Benitec, uniQure B.V. deal

Benitec granted uniQure non-exclusive, worldwide rights to Benitec's DNA-directed RNAi (ddRNAi) technology in Huntington's disease (HD). In return, Benitec receives non-exclusive worldwide rights to u...